Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
ANAB
Stock Latest News
The Fly
AnaptysBio could have positive read from J&J abstracts, says Guggenheim
1d ago
JNJ
ANAB
Premium
The Fly
AnaptysBio board authorizes $75M stock repurchase plan
2d ago
ANAB
Premium
The Fly
AnaptysBio sees cash runway through year-end 2027
2d ago
ANAB
Premium
Stock Analysis & Ideas
Wells Fargo Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks
13d ago
ANAB
ANNX
Premium
The Fly
AnaptysBio price target raised to $42 from $36 at JPMorgan
23d ago
ANAB
Premium
Ratings
Cautious Hold Rating on AnaptysBio Amid Mixed Clinical Trial Results and Strategic Uncertainties
24d ago
ANAB
Premium
The Fly
AnaptysBio price target raised to $52 from $36 at Guggenheim
25d ago
ANAB
Premium
Ratings
AnaptysBio: Strong Financial Performance and Promising Pipeline Drive Buy Rating
25d ago
ANAB
Premium
Ratings
Cautious Hold Rating on AnaptysBio Amid Uncertain Clinical Trial Outcomes and Strategic Decisions
28d ago
ANAB
Premium
Company Announcements
AnaptysBio Reports Strong Progress in Clinical Trials
28d ago
ANAB
Premium
Ratings
AnaptysBio’s Promising Clinical Trials and Strong Financial Position Earn ‘Buy’ Rating from Analyst
28d ago
ANAB
Premium
The Fly
AnaptysBio reports Q4 EPS (72c), consensus ($1.70)
28d ago
ANAB
Premium
Pre-Earnings
ANAB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
ANAB
Premium
Ratings
AnaptysBio’s Promising Prospects Highlighted by Recent Data: A Buy Recommendation by David Risinger
1M ago
ANAB
Premium
Ratings
Positive Outlook on AnaptysBio: Buy Rating Based on Undervaluation and Promising Pipeline
1M ago
ANAB
Premium
The Fly
AnaptysBio price target raised to $51 from $40 at Wells Fargo
1M ago
ANAB
Premium
Ratings
Positive Phase 2 Trial Results and Strong Safety Profile Boost Confidence in AnaptysBio’s Rosnilimab, Supporting Buy Rating and Increased Price Target
1M ago
ANAB
Premium
The Fly
AnaptysBio price target raised to $22 from $19 at H.C. Wainwright
1M ago
ANAB
Premium
The Fly
Truist says AnaptysBio handing of placebo ‘raise doubt’ about Phase 2 RA data
1M ago
ANAB
Premium
Company Announcements
AnaptysBio Announces Promising Phase 2b RENOIR Trial Results
1M ago
8K
ANAB
Premium
The Fly
AnaptysBio announces Phase 2b RENOIR trial met primary endpoint
1M ago
ANAB
Premium
Ratings
AnaptysBio’s Strong Financial Prospects Driven by Jemperli’s Growth and Strategic Partnerships
2M ago
ANAB
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
